NDC 61727-001

MetX

Metx

MetX is a Oral Solution/ Drops in the Human Otc Drug category. It is labeled and distributed by Homeocare Laboratories Inc.. The primary component is Thyroid, Unspecified; Fucus Serratus; Tribasic Calcium Phosphate; Graphite; Sodium Sulfide; Lycopodium Clavatum Spore; Sus Scrofa Placenta; Antimony Trisulfide; Bos Taurus Hypothalamus.

• Product ID: 61727-001_2d7816a3-05f7-224f-e054-00144ff88e88
• NDC: 61727-001
• Product Type: Human Otc Drug
• Proprietary Name: MetX
• Generic Name: Metx
• Dosage Form: Solution/ Drops
• Route of Administration: ORAL
• Marketing Start Date: 2016-01-20
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: Homeocare Laboratories Inc.
• Substance Name: THYROID, UNSPECIFIED; FUCUS SERRATUS; TRIBASIC CALCIUM PHOSPHATE; GRAPHITE; SODIUM SULFIDE; LYCOPODIUM CLAVATUM SPORE; SUS SCROFA PLACENTA; ANTIMONY TRISULFIDE; BOS TAURUS HYPOTHALAMUS
• Active Ingredient Strength: 4 [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 61727-001-00

1 mL in 1 BOTTLE, DROPPER (61727-001-00)

• Marketing Start Date: 2016-01-20
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 61727-001-00 [61727000100]

MetX SOLUTION/ DROPS

• Marketing Category: unapproved homeopathic
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2016-01-20
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
THYROID, UNSPECIFIED	4 [hp_C]/60mL

OpenFDA Data

• SPL SET ID: 2814761c-0f3d-32cb-e054-00144ff88e88
• Manufacturer:
  • Homeocare Laboratories Inc.
• UNII:
  • S6G2NLH4Y7
  • C88X29Y479
  • 4QQN74LH4O
  • 0B4FDL9I6P
  • C8CV8867O8
  • YGR27ZW0Y7
  • 91D9GV0Z28
  • F79059A38U
  • V8K40WNW5B